To Evaluate the Efficacy and Safety on Blood Pressure In Patients With Hypertension Diagnosed Congestive Heart Failure
A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 169 participants.
Also called NCT01682564
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 169 participants
- Registry
-
NCT01682564
-
- Start date
- (registry gives no type)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- South Korea
- Registry status
- Completed
Technical summary
Registry record NCT01682564. Randomized; no masking; primary purpose treatment. Start 2012-01 (registry gives no type); primary completion 2014-10 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- To Evaluate the Efficacy and Safety on Blood Pressure In Patients With Hypertension Diagnosed Congestive Heart Failure
- Acronym
- CANTABILE
- Condition
- Hypertension
- Condition
- Congestive Heart Failure
- Intervention (Drug)
- Candemore tablet
- Intervention (Drug)
- Atacand tablet
- Lead sponsor
- Chong Kun Dang Pharmaceutical
Record details
- Record id
cardio:ct-nct01682564- Content hash
481126357a70769cfbf784f1685e32ef20b1a0185cf379bf7d26e66e8228c735